<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Editas Medicine, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Editas Medicine, Inc.

    As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $571,000,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Cynthia Collins
    • FOUNDED
      2013
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Unity Biotechnology, Inc.

    Unity Biotechnology, Inc.

    UNITY Biotechnology is developing therapeutics to extend human healthspan by slowi...

    UNITY Biotechnology is developing therapeutics ...

    Filing Type:    PU
    Illumina, Inc.

    Illumina, Inc.

    A global leader in DNA sequencing and array-based technologies, Illumina is fuelin...

    A global leader in DNA sequencing and array-bas...

    Filing Type:    PU
    Aptevo Therapeutics Inc.

    Aptevo Therapeutics Inc.

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on deve...

    Aptevo Therapeutics Inc. is a clinical-stage bi...

    Filing Type:    PU
    Beyond Air, Inc.

    Beyond Air, Inc.

    Beyond Air Inc. is a clinical-stage medical device and biopharmaceutical company d...

    Beyond Air Inc. is a clinical-stage medical dev...

    Filing Type:    PU
    California Labs, Inc.

    California Labs, Inc.

    California Labs has developed Loop, a connected personal display for the home. Loo...

    California Labs has developed Loop, a connected...

    Amount Raised:    $293,713
    Fundraising Status:    SD
    Filing Type:    CF
    Castle Biosciences, Inc.

    Castle Biosciences, Inc.

    Castle Biosciences is a skin cancer diagnostics company focused on providing physi...

    Castle Biosciences is a skin cancer diagnostics...

    Filing Type:    PU
    Precision BioSciences, Inc.

    Precision BioSciences, Inc.

    Precision BioSciences is dedicated to improving life (DTIL) through its proprietar...

    Precision BioSciences is dedicated to improving...

    Filing Type:    PU
    LogicBio Therapeutics, Inc.

    LogicBio Therapeutics, Inc.

    LogicBio is a Cambridge, MA-based genome editing company focused on delivering the...

    LogicBio is a Cambridge, MA-based genome editin...

    Filing Type:    PU
    Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into ...

    Sangamo Therapeutics, Inc. is focused on transl...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.